Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken) | ||||||||||||||||||
Abbildung 47: EUROPA-Studie - Compliance After randomisation, study medication was well tolerated. At 3 years, 81 % of patients assigned perindopril and 84 % of placebo patients, were taking study medication. Most of the patients assigned to perindopril continued on 8 mg, only 7 % had dropped to 4 mg at 3 years. The average use of study medication was 3.7 years of 4.2 years follow-up. |
Abbildung 47: EUROPA-Studie - Compliance
After randomisation, study medication was well tolerated. At 3 years, 81 % of patients assigned perindopril and 84 % of placebo patients, were taking study medication. Most of the patients assigned to perindopril continued on 8 mg, only 7 % had dropped to 4 mg at 3 years. The average use of study medication was 3.7 years of 4.2 years follow-up. |
